相关实验视频

Updated: Jul 27, 2026

Real-time Imaging of Axonal Transport of Quantum Dot-labeled BDNF in Primary Neurons

Real-time Imaging of Axonal Transport of Quantum Dot-labeled BDNF in Primary Neurons

Published on: September 15, 2014

针对BDNF V66M变异的天然化合物:来自in silico对接和分子分析的见解

Azra Sakhawat¹, Muhammad Umer Khan², Raima Rehman¹

¹Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.

|November 28, 2023

概括

这项研究选了大脑衍生神经营养因子 (BDNF) 变体 (V66M) 的天然化合物,确定了奎尔素作为一种强大的抑制剂. 分子动力学模拟证实了奎尔丁的存在.

科学领域:

神经科学和药理学神经科学和药理学
计算机化药物发现技术

背景情况:

大脑衍生神经营养因子 (BDNF) 对于神经元的健康和功能至关重要.
该BDNF变体 (V66M) 涉及到记忆,认知和情绪障碍.

研究的目的:

选天然化合物作为BDNF变体 (V66M) 的潜在抑制剂.
为了评估所选化合物的结合亲和力,稳定性和药理动力学特性.

主要方法:

使用AUTODOCK VINA和BIOVIA发现工作室进行分子对接.
使用瑞士ADMET和瑞士Predict进行ADMET分析.
使用PyMOL和IMOD服务器进行分子动力学模拟.

主要成果:

奎尔对BDNF (V66M) 活性部位表现出最强的结合亲和力 (-6.7kJ/mol).
体形成稳定的相互作用,包括疏水性和键.
在ADMET分析中,检测到的化合物具有良好的药理动力学和毒性概况.
分子动力学模拟证实了Quercetin与目标蛋白的稳定性和动态结合.

结论:

奎尔是抑制BDNF变体 (V66M) 的有希望的候选者.
这项研究为开发针对与压力相关的BDNF (V66M) 功能障碍的新疗法提供了基础.

关键词:

大脑衍生的神经向因子甲氨酸 (Methionine) 是一种含有甲的物质.治疗疗法治疗疗法氨酸 (Valine) 是一种氨酸.

更多相关视频

An Improved Protocol to Purify and Directly Mono-Biotinylate Recombinant BDNF in a Tube for Cellular Trafficking Studies in Neurons

An Improved Protocol to Purify and Directly Mono-Biotinylate Recombinant BDNF in a Tube for Cellular Trafficking Studies in Neurons

Published on: July 11, 2020

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

相关概念视频

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...